IT Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on IT Press Releases.

Press releases published on August 4, 2026

4 minutes ago

HDTV Supply Introduces WolfPack 4K 16x16 Seamless HDMI Matrix with Video Wall, Timer & Multi-Display Modes

Indeterminate EIN Presswire

17 minutes ago

CBiLink Expands U.S. Presence with AI and Data Governance Solutions at Leading New York Financial Institutions

Indeterminate EIN Presswire

an hour ago

Brian Pulis Unveils Carbon: A Near Future Techno-Thriller, Exploring AI, Corporate Power and Human Cost

Indeterminate EIN Presswire

2 hours ago

Furuno becomes the first company in Japan to receive live signals transmitted from Xona's Pulsar LEO PNT satellite

Indeterminate EIN Presswire

2 hours ago

Labarna Moves to the Front: TFSF Ventures Completes Its Corporate Transition, Moving All Sales and Engagement to Labarna

Indeterminate EIN Presswire

6 hours ago

Fasoo AI Extends Advanced Data Protection to the Screen, Addressing an Overlooked IP Risk for Manufacturers

Indeterminate EIN Presswire

6 hours ago

GHLCentral to Spotlight Entrepreneurs at HighLevel LIVE Manila

Indeterminate EIN Presswire

21 minutes ago

IQM Quantum Computers Reports First Earnings as Public Company, Reporting First Half and Second Quarter 2026 Results, and Initiates FY 2026 Guidance Supported by Over EUR 102 million Order Backlog

Indeterminate GlobeNewswire

an hour ago

LeverageOne Strengthens Its Integrated Technology Platform for the Brokerage Industry

Indeterminate GlobeNewswire

an hour ago

Press Release: Sanofi’s MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease

Indeterminate GlobeNewswire

an hour ago

Communiqué de presse : MenQuadfi de Sanofi approuvé dans l’UE pour une utilisation chez les nourrissons dès l’âge de six semaines contre les infections invasives à méningocoques

Indeterminate GlobeNewswire

an hour ago

Wix Reports Second Quarter 2026 Results

Indeterminate GlobeNewswire

an hour ago

Nurix Therapeutics Announces First Patient Enrolled in Registrational Phase 3 DAYBreak CLL-306 Trial of Bexobrutideg in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Indeterminate GlobeNewswire